Extractor: pypdf | Pages: 4
1 Düsseldorf Local Division UPC_CFI_499/2023 Decision of the Court of First Instance of the Unified Patent Court issued on 7 January 2025 concerning EP 4 026 488 CLAIMANT: DexCom, Inc., represented by its CEO Kevin Sayer , 6340 Sequen ce Drive, San Diego, California 92121, USA, represented by: Dr Markus Grosch, Dr Johannes Bukow, Dr Jan Axtmann, Paul Lehmann, Quinn Emanuel Urquhart & Sullivan LLP, Mollstraße 42, 68165 Mannheim, Germany, electronic address for service: marcusgrosch@quinnemanuel.com DEFENDANTS: 1. Abbott Laboratories, represented by its board of directors which is represented by the CEO Robert Ford, 100 Abbott Park Road, Abbott Park, Illinois 60064-6400, USA, 2. Abbott Diabetes Care Inc., represented by its president Jared Watkin, 1360 South Loop Road, Alameda, California 94 ...